Ideal for: Early- to mid-stage biotech companies
Interim MA leadership
Strategic planning and execution
Cross-functional alignment
Outcome:
Executive-level expertise without the cost of a full-time hire.
Scientific narrative development
KOL mapping and engagement
Advisory board strategy
Field team readiness
Outcome:
Accelerated physician adoption and stronger launch execution.
KOL identification and segmentation
Engagement planning
Advisory board design
Outcome:
Stronger relationships with influential physicians.
MSL structure and deployment
Insight generation frameworks
Training and messaging
Outcome:
More effective scientific exchange and actionable insights.
Medical Affairs Strategy Canvas
Launch Readiness Assessment
KOL Mapping Sessions
Outcome:
Clear, actionable strategy aligned across leadership teams.
© Copyright 2026. SD Consulting. All rights reserved.